Puma Biotechnology (PBYI) reported first-quarter 2025 adjusted earnings of 10 cents per share, which beat the Zacks Consensus Estimate of 2 cents. In the year-ago quarter, the company had incurred a loss of 5 cents per share.The above-adjusted earnings exclude the impact of stock-based compensation expense. Including the same, earnings per share were 6 cents against a loss of 10 cents in the year-ago quarter.Total revenues were $46.0 million, which also beat the Zacks Consensus Estimate of$44.0 million.Rev ...